Product Code: ETC6188948 | Publication Date: Sep 2024 | Updated Date: Jun 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australias Postmenopausal Osteoporosis Treatment market is expanding due to an aging population and growing awareness of bone health. Treatment regimens include bisphosphonates, hormone replacement therapy, and newer monoclonal antibodies. Government healthcare initiatives and screening programs play a key role in early detection and treatment adherence.
The treatment market for postmenopausal osteoporosis in Australia is growing due to the aging female population and increased awareness about bone health. Bisphosphonates, hormone therapies, and new biologics like romosozumab are being adopted. Government subsidies for bone density tests and medications support early intervention and market expansion.
The postmenopausal osteoporosis treatment market in Australia deals with challenges including poor medication adherence among elderly patients and underdiagnosis of osteoporosis due to lack of routine screening. Side effects associated with common treatments such as bisphosphonates further reduce patient compliance and market uptake.
This market presents significant investment opportunities due to the aging Australia population and rising awareness of bone health. Companies developing biologics, hormone replacement therapies, or non-invasive treatment alternatives stand to gain. There is also scope for digital health companies offering diagnostic tools and personalized treatment monitoring platforms.
The Australia government addresses postmenopausal osteoporosis through national health frameworks, including MBS for bone density testing and PBS subsidies for bisphosphonates and other osteoporosis drugs. Osteoporosis Australia, in partnership with government health agencies, works on public health campaigns to promote early detection and long-term treatment adherence.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Postmenopausal Osteoporosis Treatment Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Postmenopausal Osteoporosis Treatment Market - Industry Life Cycle |
3.4 Australia Postmenopausal Osteoporosis Treatment Market - Porter's Five Forces |
3.5 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Australia Postmenopausal Osteoporosis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Postmenopausal Osteoporosis Treatment Market Trends |
6 Australia Postmenopausal Osteoporosis Treatment Market, By Types |
6.1 Australia Postmenopausal Osteoporosis Treatment Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Bisphosphonates, 2021- 2031F |
6.1.4 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Hormone Replacement Therapy, 2021- 2031F |
6.1.5 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Parathyroid Hormone, 2021- 2031F |
6.1.6 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Estrogen Receptor Modulators, 2021- 2031F |
6.1.7 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Other Drug Types, 2021- 2031F |
6.2 Australia Postmenopausal Osteoporosis Treatment Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.2.4 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.2.6 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.7 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3 Australia Postmenopausal Osteoporosis Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.3.4 Australia Postmenopausal Osteoporosis Treatment Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Australia Postmenopausal Osteoporosis Treatment Market Import-Export Trade Statistics |
7.1 Australia Postmenopausal Osteoporosis Treatment Market Export to Major Countries |
7.2 Australia Postmenopausal Osteoporosis Treatment Market Imports from Major Countries |
8 Australia Postmenopausal Osteoporosis Treatment Market Key Performance Indicators |
9 Australia Postmenopausal Osteoporosis Treatment Market - Opportunity Assessment |
9.1 Australia Postmenopausal Osteoporosis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Australia Postmenopausal Osteoporosis Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Australia Postmenopausal Osteoporosis Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Australia Postmenopausal Osteoporosis Treatment Market - Competitive Landscape |
10.1 Australia Postmenopausal Osteoporosis Treatment Market Revenue Share, By Companies, 2024 |
10.2 Australia Postmenopausal Osteoporosis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |